Eli Lilly shares down 1.7% due to Novo Nordisk's disappointing earnings

From CNBC: 2024-08-07 12:01:46

On Wednesday, U.S. stocks rebounded following a three-day losing streak. The S & P 500 rose 1.5%, with the Dow Jones Industrial Average and Nasdaq Composite up 1% and 1.9%. Eli Lilly shares fell 1.7% after Novo Nordisk’s disappointing earnings, raising concerns about Lilly’s upcoming results. Amazon’s e-commerce business got a boost as CVS Health announced plans to close 900 retail stores, driving shares up 3%.



Read more at CNBC:: Here’s why Eli Lilly is down heading into earnings — and how to play it